THE PELICAN CANCER FOUNDATION

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +33.4%

  £310,884 → £414,745

• Cash

  -27.5%

  £768,730 → £557,414

• Net assets

  +4.5%

  £865,071 → £903,843

• Employees

  0%

  3 → 3

• Wages

  +5%

  £113,689 → £119,373

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. THE PELICAN CANCER FOUNDATION 2012-01-25 → present
2. THE PELICAN CANCER FOUNDATION LTD 2010-05-25 → 2012-01-25

Accounting basis

FRS 102 §1A

Abridged

Yes — abridged accounts (limited disclosure)

Auditor

TC Group

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“At the time of approving the accounts, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the future. Thus the Trustees continue to adopt the going concern basis of the accounting in preparing the accounts.”

Significant events

• “The Charity incorporated in 2010 and the new Charity number is 1141911 (England and Wales) and the company number is 7264864 (England). The Articles of Association were revised in August 2023.”
• “In March 2024 a new Investment Committee was set up to manage Pelican's reserves and investments.”
• “A new Investment Policy and Reserves Policy were agreed by the Board based on recommendations from the Investment Committee.”
• “The Reserves Policy was updated in January 2024: The Trustees continue to hold sufficient reserves to allow the Charity and its associated activities to continue for 12 months (£300,000).”
• “Amy Lord, (AL) was appointed as a part time Research & Education Consultant for Pelican and part time Colorectal Consultant for HHFT. The start date for this appointment was 14th October 2024.”
• “In March 2025, Miss Lord was made an Honorary Clinical Senior Lecturer at Imperial College London in the Department of Surgery and Cancer.”
• “Professor Bill Heald's consultancy contract ended on 16th January 2025.”
• “A revised Risk Register was produced in March 2025 and shows significantly lower overall risk than the previous year.”
• “A GDPR Review was conducted, and actions taken to ensure compliance in all areas.”
• “During the year ended 31st March 2025, the charity generated total funds of £414,745 (2024 - £310,884), and the total spend of the charity was £366,275 (2024-£250,989).”
• “There were no capital commitments, either contracted or authorised by the Trustees, at 31 March 2025.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.